Ken Griffin Haemonetics Corp Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Haemonetics Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 36,100 shares of HAE stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,100

Previous 23,500 53.62%

Holding current value

$3.09 Million

Previous $1.94 Million 49.23%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $10.1 Million - $12.8 Million	139,795 Added 69.37%	341,317 $27.4 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $14.9 Million - $17.9 Million	183,991 Added 1049.52%	201,522 $16.7 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $1.25 Million - $1.5 Million	17,531 New	17,531 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $6,357 - $7,198	77 Added 4.55%	1,768 $158,000
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $52,222 - $57,784	-646 Reduced 27.64%	1,691 $143,000
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $234,618 - $292,185	-3,225 Reduced 57.98%	2,337 $193,000
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $171,258 - $199,758	-2,319 Reduced 29.43%	5,562 $437,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $39.9 Million - $49.6 Million	-630,563 Reduced 98.77%	7,881 $583,000
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $21.1 Million - $28.3 Million	427,869 Added 203.19%	638,444 $41.6 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $7.57 Million - $11.4 Million	152,736 Added 264.07%	210,575 $11.2 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $7.93 Million - $9.72 Million	-137,639 Reduced 70.41%	57,839 $4.08 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $9.27 Million - $21.2 Million	178,953 Added 1082.92%	195,478 $13 Million
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $5.11 Million - $6.42 Million	-46,020 Reduced 73.58%	16,525 $1.83 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $2.64 Million - $3.57 Million	-29,766 Reduced 32.25%	62,545 $7.43 Million
Q3 2020 Nov 16, 2020	SELL	$75.65 - $93.58 $5.07 Million - $6.28 Million	-67,079 Reduced 42.08%	92,311 $8.05 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $4.3 Million - $6.02 Million	50,607 Added 46.52%	159,390 $14.3 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $2.51 Million - $4.11 Million	-33,752 Reduced 23.68%	108,783 $10.8 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $12.5 Million - $14.1 Million	109,217 Added 327.8%	142,535 $16.4 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $2.68 Million - $3.17 Million	22,903 Added 219.9%	33,318 $4.2 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $3.3 Million - $4.86 Million	-40,399 Reduced 79.5%	10,415 $1.25 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $2.4 Million - $2.94 Million	28,778 Added 130.6%	50,814 $0
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $13.4 Million - $17 Million	-148,744 Reduced 87.1%	22,036 $0
Q2 2018 Aug 10, 2018	BUY	$71.53 - $95.75 $9.25 Million - $12.4 Million	129,362 Added 312.33%	170,780 $0
Q1 2018 May 11, 2018	SELL	$60.72 - $74.41 $1.85 Million - $2.27 Million	-30,526 Reduced 42.43%	41,418 $3.03 Million
Q4 2017 Feb 09, 2018	BUY	$44.96 - $58.99 $3.23 Million - $4.24 Million	71,944	71,944 $4.18 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account